Long-term Safety of Vedolizumab for the Treatment of Ulcerative Colitis or Crohn's Disease

被引：13

作者：

Colombel, Jean-Frederic ^{[1
]}

Sands, Bruce ^{[1
]}

Hanauer, Stephen ^{[2
]}

Rutgeerts, Paul ^{[3
,4
]}

Sandborn, William ^{[5
]}

Danese, Silvio ^{[6
]}

D'Haens, Geert ^{[7
]}

Panaccione, Remo ^{[8
]}

Sankoh, Serap ^{[9
]}

Fox, Irving ^{[9
]}

Parikh, Asit ^{[10
]}

Milch, Catherine ^{[9
]}

Feagan, Brian ^{[11
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY USA

[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[3] Katholieke Univ, Louvain, Belgium

[4] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[5] Univ Calif San Diego, La Jolla, CA 92093 USA

[6] Ist Clin Humanitas, Milan, Italy

[7] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[8] Univ Calgary, Calgary, AB, Canada

[9] Millennium Pharmaceut Inc, Cambridge, MA USA

[10] Takeda Pharmaceut Int Inc, Deerfield, IL USA

[11] Univ Western Ontario, Robarts Res Inst, London, ON, Canada

来源：

关键词：

D O I：

10.14309/00000434-201310001-01674

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1674

引用

页码：S502 / S503

页数：2